

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sarcomere organization (GO:0045214) | 6.05009116 |
| 2 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 5.80534800 |
| 3 | cardiac myofibril assembly (GO:0055003) | 5.23143612 |
| 4 | actin-myosin filament sliding (GO:0033275) | 5.15411809 |
| 5 | muscle filament sliding (GO:0030049) | 5.15411809 |
| 6 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 5.00729764 |
| 7 | myofibril assembly (GO:0030239) | 4.94519617 |
| 8 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 4.87410160 |
| 9 | plasma membrane repair (GO:0001778) | 4.84168642 |
| 10 | regulation of skeletal muscle contraction (GO:0014819) | 4.39990768 |
| 11 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.38039532 |
| 12 | actin-mediated cell contraction (GO:0070252) | 4.35537897 |
| 13 | cardiac muscle cell development (GO:0055013) | 4.32234561 |
| 14 | fatty acid transmembrane transport (GO:1902001) | 4.09532544 |
| 15 | carnitine shuttle (GO:0006853) | 4.08058984 |
| 16 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 4.04009899 |
| 17 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.00445831 |
| 18 | carnitine transmembrane transport (GO:1902603) | 3.99743270 |
| 19 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.99555974 |
| 20 | cardiac cell development (GO:0055006) | 3.98021489 |
| 21 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.95423765 |
| 22 | cytidine metabolic process (GO:0046087) | 3.84234370 |
| 23 | cytidine catabolic process (GO:0006216) | 3.84234370 |
| 24 | cytidine deamination (GO:0009972) | 3.84234370 |
| 25 | cardiac muscle contraction (GO:0060048) | 3.81496340 |
| 26 | cell wall macromolecule catabolic process (GO:0016998) | 3.78806804 |
| 27 | cell wall macromolecule metabolic process (GO:0044036) | 3.78806804 |
| 28 | amino-acid betaine transport (GO:0015838) | 3.78427026 |
| 29 | carnitine transport (GO:0015879) | 3.78427026 |
| 30 | tricarboxylic acid cycle (GO:0006099) | 3.76661661 |
| 31 | heart process (GO:0003015) | 3.76397205 |
| 32 | heart contraction (GO:0060047) | 3.76397205 |
| 33 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.74601452 |
| 34 | cardiac muscle hypertrophy (GO:0003300) | 3.73856706 |
| 35 | fusion of sperm to egg plasma membrane (GO:0007342) | 3.70591727 |
| 36 | acrosome assembly (GO:0001675) | 3.69471115 |
| 37 | regulation of relaxation of muscle (GO:1901077) | 3.68292888 |
| 38 | actomyosin structure organization (GO:0031032) | 3.64965804 |
| 39 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.61217622 |
| 40 | sperm motility (GO:0030317) | 3.56693807 |
| 41 | striated muscle hypertrophy (GO:0014897) | 3.53478751 |
| 42 | regulation of sequestering of triglyceride (GO:0010889) | 3.51022251 |
| 43 | desmosome organization (GO:0002934) | 3.49894707 |
| 44 | negative regulation of protein localization to cell surface (GO:2000009) | 3.48322684 |
| 45 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.47575348 |
| 46 | multicellular organism reproduction (GO:0032504) | 3.43354930 |
| 47 | actin filament-based movement (GO:0030048) | 3.42826822 |
| 48 | muscle hypertrophy (GO:0014896) | 3.38380044 |
| 49 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.34851444 |
| 50 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.33314573 |
| 51 | striated muscle contraction (GO:0006941) | 3.30876292 |
| 52 | low-density lipoprotein particle clearance (GO:0034383) | 3.29605607 |
| 53 | regulation of actin filament-based movement (GO:1903115) | 3.26683608 |
| 54 | response to inactivity (GO:0014854) | 3.26451511 |
| 55 | sperm-egg recognition (GO:0035036) | 3.15812628 |
| 56 | skeletal muscle adaptation (GO:0043501) | 3.14961910 |
| 57 | positive regulation of lipid storage (GO:0010884) | 3.13435005 |
| 58 | regulation of p38MAPK cascade (GO:1900744) | 3.13199579 |
| 59 | fibroblast migration (GO:0010761) | 3.08531875 |
| 60 | intracellular lipid transport (GO:0032365) | 3.06171296 |
| 61 | muscle tissue morphogenesis (GO:0060415) | 3.03619628 |
| 62 | striated muscle atrophy (GO:0014891) | 3.02969741 |
| 63 | negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394) | 3.00589012 |
| 64 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.99225378 |
| 65 | cellular response to epinephrine stimulus (GO:0071872) | 2.97858959 |
| 66 | reproduction (GO:0000003) | 2.97083034 |
| 67 | regulation of sarcomere organization (GO:0060297) | 2.96981778 |
| 68 | response to peptidoglycan (GO:0032494) | 2.96374335 |
| 69 | regulation of cholesterol storage (GO:0010885) | 2.94328729 |
| 70 | cellular extravasation (GO:0045123) | 2.90627182 |
| 71 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 2.89944988 |
| 72 | muscle atrophy (GO:0014889) | 2.89910463 |
| 73 | plasma membrane fusion (GO:0045026) | 2.89647387 |
| 74 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.88969536 |
| 75 | regulation of striated muscle contraction (GO:0006942) | 2.88489248 |
| 76 | pericardium development (GO:0060039) | 2.86511025 |
| 77 | regulation of cell communication by electrical coupling (GO:0010649) | 2.85293677 |
| 78 | cell-cell recognition (GO:0009988) | 2.84741956 |
| 79 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.83604961 |
| 80 | sequestering of metal ion (GO:0051238) | 2.82733092 |
| 81 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.81828769 |
| 82 | modulation by symbiont of host immune response (GO:0052553) | 2.81828769 |
| 83 | positive regulation by symbiont of host defense response (GO:0052509) | 2.81828769 |
| 84 | modulation by symbiont of host defense response (GO:0052031) | 2.81828769 |
| 85 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.81828769 |
| 86 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.81828769 |
| 87 | heart trabecula formation (GO:0060347) | 2.81719587 |
| 88 | cell communication involved in cardiac conduction (GO:0086065) | 2.80206964 |
| 89 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.79706013 |
| 90 | natural killer cell mediated immunity (GO:0002228) | 2.79165230 |
| 91 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.79165230 |
| 92 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.78233660 |
| 93 | macroautophagy (GO:0016236) | 2.78032387 |
| 94 | response to epinephrine (GO:0071871) | 2.77136614 |
| 95 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.74859270 |
| 96 | muscle contraction (GO:0006936) | 2.73377883 |
| 97 | binding of sperm to zona pellucida (GO:0007339) | 2.73320992 |
| 98 | regulation of cardioblast differentiation (GO:0051890) | 2.72008668 |
| 99 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.71873457 |
| 100 | regulation of the force of heart contraction (GO:0002026) | 2.71132545 |
| 101 | phospholipid homeostasis (GO:0055091) | 2.71096401 |
| 102 | lysine catabolic process (GO:0006554) | 2.66371966 |
| 103 | lysine metabolic process (GO:0006553) | 2.66371966 |
| 104 | adhesion of symbiont to host cell (GO:0044650) | 2.65556693 |
| 105 | virion attachment to host cell (GO:0019062) | 2.65556693 |
| 106 | skeletal muscle contraction (GO:0003009) | 2.63719917 |
| 107 | cell migration involved in heart development (GO:0060973) | 2.62544989 |
| 108 | muscle adaptation (GO:0043500) | 2.62390701 |
| 109 | relaxation of cardiac muscle (GO:0055119) | 2.62049819 |
| 110 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.61596979 |
| 111 | striated muscle adaptation (GO:0014888) | 2.60011148 |
| 112 | hypotonic response (GO:0006971) | 2.59960683 |
| 113 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.58311028 |
| 114 | fatty acid beta-oxidation (GO:0006635) | 2.57759904 |
| 115 | endocardial cushion development (GO:0003197) | 2.57724391 |
| 116 | positive regulation of glycolytic process (GO:0045821) | 2.57506515 |
| 117 | muscle system process (GO:0003012) | 2.55956318 |
| 118 | positive regulation of p38MAPK cascade (GO:1900745) | 2.55934689 |
| 119 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.52943467 |
| 120 | interkinetic nuclear migration (GO:0022027) | 2.47160683 |
| 121 | cell-substrate junction assembly (GO:0007044) | 2.40113840 |
| 122 | growth hormone receptor signaling pathway (GO:0060396) | 2.37056342 |
| 123 | regulation of muscle system process (GO:0090257) | 2.34187733 |
| 124 | regulation of muscle contraction (GO:0006937) | 2.32649128 |
| 125 | response to muscle activity (GO:0014850) | 2.32227510 |
| 126 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.31377412 |
| 127 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.30385221 |
| 128 | negative regulation of lipid storage (GO:0010888) | 2.28693413 |
| 129 | hemidesmosome assembly (GO:0031581) | 2.27794094 |
| 130 | cell adhesion mediated by integrin (GO:0033627) | 2.27447654 |
| 131 | regulation of necroptotic process (GO:0060544) | 2.26556397 |
| 132 | establishment of protein localization to Golgi (GO:0072600) | 2.23777668 |
| 133 | relaxation of muscle (GO:0090075) | 2.20138111 |
| 134 | response to redox state (GO:0051775) | 2.19807400 |
| 135 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.19802358 |
| 136 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.18208056 |
| 137 | regulation of cardiac muscle hypertrophy (GO:0010611) | 2.17779699 |
| 138 | negative regulation of anoikis (GO:2000811) | 2.17444244 |
| 139 | skin morphogenesis (GO:0043589) | 2.16926326 |
| 140 | protein targeting to Golgi (GO:0000042) | 2.15805257 |
| 141 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.14941949 |
| 142 | negative regulation of vascular permeability (GO:0043116) | 2.14514908 |
| 143 | regulation of cardiac muscle contraction (GO:0055117) | 2.13406955 |
| 144 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.13199357 |
| 145 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.12533150 |
| 146 | adhesion of symbiont to host (GO:0044406) | 2.12437405 |
| 147 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.11532439 |
| 148 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.11532439 |
| 149 | regulation of muscle hypertrophy (GO:0014743) | 2.10602060 |
| 150 | import into cell (GO:0098657) | 2.10346481 |
| 151 | interleukin-6-mediated signaling pathway (GO:0070102) | 2.10139067 |
| 152 | cellular response to growth hormone stimulus (GO:0071378) | 2.06636028 |
| 153 | regulation of vitamin metabolic process (GO:0030656) | 2.06605429 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.88785218 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.67836555 |
| 3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.34150931 |
| 4 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 3.22676169 |
| 5 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.71108606 |
| 6 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.68515678 |
| 7 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.68272411 |
| 8 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.60624794 |
| 9 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.52298883 |
| 10 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.44398168 |
| 11 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.39622569 |
| 12 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.38236377 |
| 13 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.37628117 |
| 14 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.24485387 |
| 15 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.24485387 |
| 16 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.14187679 |
| 17 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.08808451 |
| 18 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.02898190 |
| 19 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.00367530 |
| 20 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.95122574 |
| 21 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.94755584 |
| 22 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.92406274 |
| 23 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.91739133 |
| 24 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.90899148 |
| 25 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.90781825 |
| 26 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.85753042 |
| 27 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.85150715 |
| 28 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.83575079 |
| 29 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.83266359 |
| 30 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.82790087 |
| 31 | TP53_16413492_ChIP-PET_HCT116_Human | 1.80253635 |
| 32 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.80140451 |
| 33 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.80140451 |
| 34 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.79194232 |
| 35 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.70812386 |
| 36 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.70650640 |
| 37 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.69879140 |
| 38 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.67489143 |
| 39 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.63904005 |
| 40 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.63070356 |
| 41 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.61904550 |
| 42 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.59958015 |
| 43 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 1.59663020 |
| 44 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.56923089 |
| 45 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.51967642 |
| 46 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.50241312 |
| 47 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.45331014 |
| 48 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.41456443 |
| 49 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.40726662 |
| 50 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.37658838 |
| 51 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.35722697 |
| 52 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.35358783 |
| 53 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.34136908 |
| 54 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.33718551 |
| 55 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.32114380 |
| 56 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.30720770 |
| 57 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.28836937 |
| 58 | GATA1_22025678_ChIP-Seq_K562_Human | 1.26382044 |
| 59 | ATF3_27146783_Chip-Seq_COLON_Human | 1.24301290 |
| 60 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.23983048 |
| 61 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.23750114 |
| 62 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.22194357 |
| 63 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.21801817 |
| 64 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.21743817 |
| 65 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.20721046 |
| 66 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.20250281 |
| 67 | GATA1_19941826_ChIP-Seq_K562_Human | 1.20239782 |
| 68 | SPI1_23127762_ChIP-Seq_K562_Human | 1.16462080 |
| 69 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.16173951 |
| 70 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.15738198 |
| 71 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.15736455 |
| 72 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.14893006 |
| 73 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.14221550 |
| 74 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.13604525 |
| 75 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.13329636 |
| 76 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.13259495 |
| 77 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.12389690 |
| 78 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.11933336 |
| 79 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.10437724 |
| 80 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.10437724 |
| 81 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.09962431 |
| 82 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.08460890 |
| 83 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.07474825 |
| 84 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.06386603 |
| 85 | CJUN_26792858_Chip-Seq_BT549_Human | 1.06222675 |
| 86 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.05952535 |
| 87 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.04120667 |
| 88 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.03467274 |
| 89 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.03158710 |
| 90 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.02096191 |
| 91 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.02008734 |
| 92 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.01950504 |
| 93 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.01669143 |
| 94 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.01598860 |
| 95 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.00555016 |
| 96 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.00396408 |
| 97 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.99955616 |
| 98 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99849174 |
| 99 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.99189953 |
| 100 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.99124496 |
| 101 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.98030090 |
| 102 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.97318577 |
| 103 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.96527479 |
| 104 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.96371497 |
| 105 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.95481040 |
| 106 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.95351273 |
| 107 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.95171045 |
| 108 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.94903475 |
| 109 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.92477363 |
| 110 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.92464503 |
| 111 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.92460120 |
| 112 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.92089737 |
| 113 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.91790363 |
| 114 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.91592155 |
| 115 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.91557272 |
| 116 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.91245541 |
| 117 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.91071830 |
| 118 | GATA2_19941826_ChIP-Seq_K562_Human | 0.90745588 |
| 119 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.90684049 |
| 120 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90019886 |
| 121 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.90012719 |
| 122 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.89953961 |
| 123 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.88944552 |
| 124 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.88492492 |
| 125 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88302725 |
| 126 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.88241880 |
| 127 | * CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.88126405 |
| 128 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.88045821 |
| 129 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.87872442 |
| 130 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.87387155 |
| 131 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.86732586 |
| 132 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.86677975 |
| 133 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.86358399 |
| 134 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.85053720 |
| 135 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.85028391 |
| 136 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.84390794 |
| 137 | * TP63_23658742_ChIP-Seq_EP156T_Human | 0.84244133 |
| 138 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.84006708 |
| 139 | * STAT3_23295773_ChIP-Seq_U87_Human | 0.83245139 |
| 140 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.83137371 |
| 141 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.82967471 |
| 142 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.82784490 |
| 143 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.82266151 |
| 144 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.82196911 |
| 145 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.81486189 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003646_muscle_fatigue | 4.58992642 |
| 2 | MP0002837_dystrophic_cardiac_calcinosis | 4.34330814 |
| 3 | MP0004084_abnormal_cardiac_muscle | 3.80019404 |
| 4 | MP0000751_myopathy | 3.09205071 |
| 5 | MP0000749_muscle_degeneration | 3.01671855 |
| 6 | MP0004036_abnormal_muscle_relaxation | 2.93515189 |
| 7 | MP0008438_abnormal_cutaneous_collagen | 2.84537235 |
| 8 | MP0004510_myositis | 2.84040897 |
| 9 | MP0004215_abnormal_myocardial_fiber | 2.68989324 |
| 10 | MP0005330_cardiomyopathy | 2.48718560 |
| 11 | MP0004087_abnormal_muscle_fiber | 2.47593983 |
| 12 | MP0004130_abnormal_muscle_cell | 2.42856444 |
| 13 | MP0005410_abnormal_fertilization | 2.38855249 |
| 14 | MP0002972_abnormal_cardiac_muscle | 2.29955628 |
| 15 | MP0003279_aneurysm | 2.25449082 |
| 16 | MP0000750_abnormal_muscle_regeneration | 2.19711965 |
| 17 | MP0003828_pulmonary_edema | 2.17398116 |
| 18 | MP0003303_peritoneal_inflammation | 2.15112646 |
| 19 | MP0008775_abnormal_heart_ventricle | 2.14685888 |
| 20 | MP0009840_abnormal_foam_cell | 2.09761278 |
| 21 | MP0001958_emphysema | 2.05174677 |
| 22 | MP0010630_abnormal_cardiac_muscle | 2.01345144 |
| 23 | MP0005275_abnormal_skin_tensile | 1.94399516 |
| 24 | MP0003566_abnormal_cell_adhesion | 1.93890081 |
| 25 | MP0004484_altered_response_of | 1.92496501 |
| 26 | MP0005620_abnormal_muscle_contractility | 1.90481369 |
| 27 | MP0002106_abnormal_muscle_physiology | 1.88147256 |
| 28 | MP0001544_abnormal_cardiovascular_syste | 1.86232192 |
| 29 | MP0005385_cardiovascular_system_phenoty | 1.86232192 |
| 30 | MP0000569_abnormal_digit_pigmentation | 1.84776860 |
| 31 | MP0008004_abnormal_stomach_pH | 1.76981135 |
| 32 | MP0002269_muscular_atrophy | 1.76141609 |
| 33 | MP0003091_abnormal_cell_migration | 1.73596873 |
| 34 | MP0000343_altered_response_to | 1.73544755 |
| 35 | MP0004145_abnormal_muscle_electrophysio | 1.67582232 |
| 36 | MP0005670_abnormal_white_adipose | 1.67264096 |
| 37 | MP0003221_abnormal_cardiomyocyte_apopto | 1.66437143 |
| 38 | MP0005451_abnormal_body_composition | 1.65712882 |
| 39 | MP0005666_abnormal_adipose_tissue | 1.60597719 |
| 40 | MP0004185_abnormal_adipocyte_glucose | 1.55909817 |
| 41 | MP0003705_abnormal_hypodermis_morpholog | 1.54159548 |
| 42 | MP0005023_abnormal_wound_healing | 1.52700741 |
| 43 | MP0003436_decreased_susceptibility_to | 1.50798849 |
| 44 | MP0010234_abnormal_vibrissa_follicle | 1.43880200 |
| 45 | MP0004272_abnormal_basement_membrane | 1.43877073 |
| 46 | MP0006054_spinal_hemorrhage | 1.43404950 |
| 47 | MP0000747_muscle_weakness | 1.42997365 |
| 48 | MP0003950_abnormal_plasma_membrane | 1.42154081 |
| 49 | MP0002234_abnormal_pharynx_morphology | 1.41800705 |
| 50 | MP0000759_abnormal_skeletal_muscle | 1.36692346 |
| 51 | MP0002877_abnormal_melanocyte_morpholog | 1.35190881 |
| 52 | MP0005058_abnormal_lysosome_morphology | 1.32772727 |
| 53 | MP0005503_abnormal_tendon_morphology | 1.32704322 |
| 54 | MP0005369_muscle_phenotype | 1.30276205 |
| 55 | MP0003191_abnormal_cellular_cholesterol | 1.28628368 |
| 56 | MP0001542_abnormal_bone_strength | 1.28589271 |
| 57 | MP0006138_congestive_heart_failure | 1.24836514 |
| 58 | MP0000013_abnormal_adipose_tissue | 1.24324794 |
| 59 | MP0002139_abnormal_hepatobiliary_system | 1.24091446 |
| 60 | MP0003137_abnormal_impulse_conducting | 1.21289764 |
| 61 | MP0006036_abnormal_mitochondrial_physio | 1.18014734 |
| 62 | MP0002332_abnormal_exercise_endurance | 1.14698754 |
| 63 | MP0005164_abnormal_response_to | 1.13442942 |
| 64 | MP0003195_calcinosis | 1.12725290 |
| 65 | MP0004947_skin_inflammation | 1.12427550 |
| 66 | MP0009785_altered_susceptibility_to | 1.11531303 |
| 67 | MP0005319_abnormal_enzyme/_coenzyme | 1.06864971 |
| 68 | MP0005085_abnormal_gallbladder_physiolo | 1.05850872 |
| 69 | MP0005595_abnormal_vascular_smooth | 1.05444473 |
| 70 | MP0002998_abnormal_bone_remodeling | 1.03417795 |
| 71 | MP0002108_abnormal_muscle_morphology | 1.02750558 |
| 72 | MP0004085_abnormal_heartbeat | 0.99528219 |
| 73 | MP0005257_abnormal_intraocular_pressure | 0.99422696 |
| 74 | MP0002971_abnormal_brown_adipose | 0.97552364 |
| 75 | MP0003724_increased_susceptibility_to | 0.96106383 |
| 76 | MP0005375_adipose_tissue_phenotype | 0.94462185 |
| 77 | MP0002896_abnormal_bone_mineralization | 0.93463815 |
| 78 | MP0009384_cardiac_valve_regurgitation | 0.93297541 |
| 79 | MP0005076_abnormal_cell_differentiation | 0.92310340 |
| 80 | MP0003300_gastrointestinal_ulcer | 0.92233905 |
| 81 | MP0003453_abnormal_keratinocyte_physiol | 0.92155172 |
| 82 | MP0005365_abnormal_bile_salt | 0.91561864 |
| 83 | MP0002127_abnormal_cardiovascular_syste | 0.91313352 |
| 84 | MP0003252_abnormal_bile_duct | 0.90522288 |
| 85 | MP0005165_increased_susceptibility_to | 0.88181912 |
| 86 | MP0002419_abnormal_innate_immunity | 0.87494642 |
| 87 | MP0000230_abnormal_systemic_arterial | 0.86789226 |
| 88 | MP0010352_gastrointestinal_tract_polyps | 0.85651964 |
| 89 | MP0004233_abnormal_muscle_weight | 0.85605847 |
| 90 | MP0005360_urolithiasis | 0.85465771 |
| 91 | MP0000249_abnormal_blood_vessel | 0.85187503 |
| 92 | MP0000733_abnormal_muscle_development | 0.84057700 |
| 93 | MP0002796_impaired_skin_barrier | 0.83049292 |
| 94 | MP0003045_fibrosis | 0.82202592 |
| 95 | MP0005083_abnormal_biliary_tract | 0.80656638 |
| 96 | MP0003941_abnormal_skin_development | 0.80546128 |
| 97 | MP0002148_abnormal_hypersensitivity_rea | 0.79538309 |
| 98 | MP0000266_abnormal_heart_morphology | 0.78955653 |
| 99 | MP0005166_decreased_susceptibility_to | 0.77751904 |
| 100 | MP0002295_abnormal_pulmonary_circulatio | 0.77691994 |
| 101 | MP0001851_eye_inflammation | 0.77344158 |
| 102 | MP0001835_abnormal_antigen_presentation | 0.77000086 |
| 103 | MP0005464_abnormal_platelet_physiology | 0.76761446 |
| 104 | MP0001765_abnormal_ion_homeostasis | 0.76217139 |
| 105 | MP0001666_abnormal_nutrient_absorption | 0.75591417 |
| 106 | MP0002118_abnormal_lipid_homeostasis | 0.75580253 |
| 107 | MP0003183_abnormal_peptide_metabolism | 0.75278212 |
| 108 | MP0001879_abnormal_lymphatic_vessel | 0.74246754 |
| 109 | MP0005025_abnormal_response_to | 0.74240297 |
| 110 | MP0005167_abnormal_blood-brain_barrier | 0.74165383 |
| 111 | MP0002128_abnormal_blood_circulation | 0.73399958 |
| 112 | MP0002693_abnormal_pancreas_physiology | 0.72999168 |
| 113 | MP0008875_abnormal_xenobiotic_pharmacok | 0.72570537 |
| 114 | MP0009764_decreased_sensitivity_to | 0.71068789 |
| 115 | MP0002078_abnormal_glucose_homeostasis | 0.70805688 |
| 116 | MP0009278_abnormal_bone_marrow | 0.70799993 |
| 117 | MP0002909_abnormal_adrenal_gland | 0.69885922 |
| 118 | MP0000003_abnormal_adipose_tissue | 0.69734269 |
| 119 | MP0000609_abnormal_liver_physiology | 0.69682364 |
| 120 | MP0008469_abnormal_protein_level | 0.69663260 |
| 121 | MP0009115_abnormal_fat_cell | 0.67079388 |
| 122 | MP0010329_abnormal_lipoprotein_level | 0.66556171 |
| 123 | MP0005334_abnormal_fat_pad | 0.65934684 |
| 124 | MP0002638_abnormal_pupillary_reflex | 0.65538899 |
| 125 | MP0003656_abnormal_erythrocyte_physiolo | 0.65371718 |
| 126 | MP0010368_abnormal_lymphatic_system | 0.64927042 |
| 127 | MP0009643_abnormal_urine_homeostasis | 0.64917256 |
| 128 | MP0000767_abnormal_smooth_muscle | 0.64592958 |
| 129 | MP0006082_CNS_inflammation | 0.63155467 |
| 130 | MP0004883_abnormal_blood_vessel | 0.62942327 |
| 131 | MP0005390_skeleton_phenotype | 0.62810455 |
| 132 | MP0009780_abnormal_chondrocyte_physiolo | 0.62582957 |
| 133 | MP0002060_abnormal_skin_morphology | 0.62497222 |
| 134 | MP0005266_abnormal_metabolism | 0.62308211 |
| 135 | MP0001533_abnormal_skeleton_physiology | 0.62085539 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sudden death (HP:0001699) | 6.32480783 |
| 2 | Ventricular tachycardia (HP:0004756) | 5.58512901 |
| 3 | Right ventricular cardiomyopathy (HP:0011663) | 5.20196318 |
| 4 | Exercise-induced muscle cramps (HP:0003710) | 5.18154104 |
| 5 | Hyporeflexia of lower limbs (HP:0002600) | 4.59697837 |
| 6 | Muscle fiber splitting (HP:0003555) | 4.50176492 |
| 7 | Exercise-induced myalgia (HP:0003738) | 4.43006908 |
| 8 | Calf muscle hypertrophy (HP:0008981) | 4.23461429 |
| 9 | Asymmetric septal hypertrophy (HP:0001670) | 4.07723971 |
| 10 | Myoglobinuria (HP:0002913) | 4.05043063 |
| 11 | Syncope (HP:0001279) | 4.04884745 |
| 12 | Bundle branch block (HP:0011710) | 3.96135630 |
| 13 | Atrial fibrillation (HP:0005110) | 3.94792741 |
| 14 | Lipoatrophy (HP:0100578) | 3.91255917 |
| 15 | Difficulty climbing stairs (HP:0003551) | 3.90562445 |
| 16 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.86020501 |
| 17 | Subaortic stenosis (HP:0001682) | 3.84078874 |
| 18 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.84078874 |
| 19 | Aortic aneurysm (HP:0004942) | 3.72992141 |
| 20 | Increased connective tissue (HP:0009025) | 3.64567968 |
| 21 | Abnormality of the calf musculature (HP:0001430) | 3.64346314 |
| 22 | Primary atrial arrhythmia (HP:0001692) | 3.62535994 |
| 23 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 3.43002213 |
| 24 | Supraventricular tachycardia (HP:0004755) | 3.42162826 |
| 25 | EMG: myopathic abnormalities (HP:0003458) | 3.39211526 |
| 26 | Supraventricular arrhythmia (HP:0005115) | 3.35043525 |
| 27 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.30209721 |
| 28 | Hypoglycemic coma (HP:0001325) | 3.27894279 |
| 29 | Rhabdomyolysis (HP:0003201) | 3.26665876 |
| 30 | Ventricular arrhythmia (HP:0004308) | 3.25998411 |
| 31 | Increased variability in muscle fiber diameter (HP:0003557) | 3.25500770 |
| 32 | Muscle fiber inclusion bodies (HP:0100299) | 3.22358852 |
| 33 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.21504976 |
| 34 | Protrusio acetabuli (HP:0003179) | 3.19793966 |
| 35 | Dilated cardiomyopathy (HP:0001644) | 3.19472202 |
| 36 | Abnormal atrioventricular conduction (HP:0005150) | 3.15439174 |
| 37 | Round ear (HP:0100830) | 3.09899028 |
| 38 | Heart block (HP:0012722) | 3.07911241 |
| 39 | Palpitations (HP:0001962) | 3.04399017 |
| 40 | Type 1 muscle fiber predominance (HP:0003803) | 3.02485715 |
| 41 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.89392397 |
| 42 | Prolonged QT interval (HP:0001657) | 2.88880965 |
| 43 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.87939303 |
| 44 | Hyperglycemia (HP:0003074) | 2.82119142 |
| 45 | Scapular winging (HP:0003691) | 2.80267288 |
| 46 | Spinal rigidity (HP:0003306) | 2.79659277 |
| 47 | Distal lower limb muscle weakness (HP:0009053) | 2.79121757 |
| 48 | Difficulty running (HP:0009046) | 2.72151605 |
| 49 | Atrioventricular block (HP:0001678) | 2.67375615 |
| 50 | Hip contracture (HP:0003273) | 2.66665964 |
| 51 | Nemaline bodies (HP:0003798) | 2.65738105 |
| 52 | Hypoalphalipoproteinemia (HP:0003233) | 2.65539485 |
| 53 | Aortic dissection (HP:0002647) | 2.64125269 |
| 54 | Eczematoid dermatitis (HP:0000976) | 2.63751496 |
| 55 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.62326624 |
| 56 | Nasal polyposis (HP:0100582) | 2.62213870 |
| 57 | Follicular hyperkeratosis (HP:0007502) | 2.51075411 |
| 58 | Ventricular fibrillation (HP:0001663) | 2.50668903 |
| 59 | Rimmed vacuoles (HP:0003805) | 2.43926719 |
| 60 | Abnormality of the nasal mucosa (HP:0000433) | 2.43082554 |
| 61 | Premature rupture of membranes (HP:0001788) | 2.39098644 |
| 62 | Areflexia of lower limbs (HP:0002522) | 2.38463503 |
| 63 | Recurrent abscess formation (HP:0002722) | 2.37921990 |
| 64 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.36265144 |
| 65 | Absent/shortened dynein arms (HP:0200106) | 2.33485587 |
| 66 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.33485587 |
| 67 | Ketoacidosis (HP:0001993) | 2.32116938 |
| 68 | Frequent falls (HP:0002359) | 2.29491898 |
| 69 | Vascular tortuosity (HP:0004948) | 2.29262596 |
| 70 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.26519297 |
| 71 | Osteolytic defects of the hand bones (HP:0009699) | 2.26160285 |
| 72 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.26160285 |
| 73 | Atrophic scars (HP:0001075) | 2.25349881 |
| 74 | Spondylolisthesis (HP:0003302) | 2.24511995 |
| 75 | Myocardial infarction (HP:0001658) | 2.23677497 |
| 76 | Limited hip movement (HP:0008800) | 2.22761993 |
| 77 | Neck muscle weakness (HP:0000467) | 2.20029977 |
| 78 | EMG: neuropathic changes (HP:0003445) | 2.19915727 |
| 79 | Chronic bronchitis (HP:0004469) | 2.19788905 |
| 80 | Recurrent bacterial skin infections (HP:0005406) | 2.19621403 |
| 81 | Nausea (HP:0002018) | 2.14410350 |
| 82 | Mitral stenosis (HP:0001718) | 2.13882647 |
| 83 | Limb-girdle muscle atrophy (HP:0003797) | 2.10864648 |
| 84 | Palmoplantar keratoderma (HP:0000982) | 2.09483374 |
| 85 | Axonal loss (HP:0003447) | 2.09063286 |
| 86 | Abnormality of the foot musculature (HP:0001436) | 2.08556261 |
| 87 | Overgrowth (HP:0001548) | 2.07168168 |
| 88 | Foot dorsiflexor weakness (HP:0009027) | 2.06558363 |
| 89 | Gowers sign (HP:0003391) | 2.06039184 |
| 90 | Aneurysm (HP:0002617) | 2.04361295 |
| 91 | Polycythemia (HP:0001901) | 2.03302828 |
| 92 | Xanthomatosis (HP:0000991) | 2.01352123 |
| 93 | Neoplasm of head and neck (HP:0012288) | 2.00587442 |
| 94 | Esophageal neoplasm (HP:0100751) | 2.00587442 |
| 95 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.98823560 |
| 96 | Arterial tortuosity (HP:0005116) | 1.98656491 |
| 97 | Myotonia (HP:0002486) | 1.96463222 |
| 98 | Facial diplegia (HP:0001349) | 1.95678619 |
| 99 | Distal arthrogryposis (HP:0005684) | 1.95453612 |
| 100 | Ketosis (HP:0001946) | 1.95405387 |
| 101 | Myopathic facies (HP:0002058) | 1.94365138 |
| 102 | Achilles tendon contracture (HP:0001771) | 1.93320094 |
| 103 | Bulbar palsy (HP:0001283) | 1.92957375 |
| 104 | Wormian bones (HP:0002645) | 1.92576202 |
| 105 | Generalized muscle weakness (HP:0003324) | 1.92222069 |
| 106 | Muscular dystrophy (HP:0003560) | 1.90802740 |
| 107 | Slender build (HP:0001533) | 1.88988204 |
| 108 | Metaphyseal dysplasia (HP:0100255) | 1.88511291 |
| 109 | Limb-girdle muscle weakness (HP:0003325) | 1.88091372 |
| 110 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.87751308 |
| 111 | Dicarboxylic aciduria (HP:0003215) | 1.87751308 |
| 112 | Neonatal short-limb short stature (HP:0008921) | 1.87171574 |
| 113 | Skin nodule (HP:0200036) | 1.86986948 |
| 114 | Tetraparesis (HP:0002273) | 1.85485788 |
| 115 | Abnormal EKG (HP:0003115) | 1.84654774 |
| 116 | Abnormality of the Achilles tendon (HP:0005109) | 1.83248050 |
| 117 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.82737754 |
| 118 | Distal lower limb amyotrophy (HP:0008944) | 1.82466169 |
| 119 | Hypoplasia of the iris (HP:0007676) | 1.81872203 |
| 120 | Late onset (HP:0003584) | 1.81661964 |
| 121 | Sudden cardiac death (HP:0001645) | 1.80024250 |
| 122 | Flat acetabular roof (HP:0003180) | 1.79325052 |
| 123 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.79260319 |
| 124 | Knee flexion contracture (HP:0006380) | 1.76424612 |
| 125 | Generalized aminoaciduria (HP:0002909) | 1.75024512 |
| 126 | Muscle stiffness (HP:0003552) | 1.74025517 |
| 127 | Thick nail (HP:0001805) | 1.73980954 |
| 128 | Bradycardia (HP:0001662) | 1.72812421 |
| 129 | Increased muscle lipid content (HP:0009058) | 1.71864736 |
| 130 | Progressive muscle weakness (HP:0003323) | 1.71039206 |
| 131 | Steppage gait (HP:0003376) | 1.70520667 |
| 132 | Weak cry (HP:0001612) | 1.70191879 |
| 133 | Peritonitis (HP:0002586) | 1.70179179 |
| 134 | Cardiovascular calcification (HP:0011915) | 1.70031217 |
| 135 | Hyperkalemia (HP:0002153) | 1.69449549 |
| 136 | Ulnar deviation of the wrist (HP:0003049) | 1.69167679 |
| 137 | Lower limb amyotrophy (HP:0007210) | 1.69057437 |
| 138 | Aplasia of the musculature (HP:0100854) | 1.68122585 |
| 139 | Insulin resistance (HP:0000855) | 1.66846275 |
| 140 | Hypolipoproteinemia (HP:0010981) | 1.66136068 |
| 141 | Fatigable weakness (HP:0003473) | 1.65293339 |
| 142 | Abnormality of the neuromuscular junction (HP:0003398) | 1.65293339 |
| 143 | Conjunctival hamartoma (HP:0100780) | 1.65136815 |
| 144 | Easy fatigability (HP:0003388) | 1.64280907 |
| 145 | Abnormality of macrophages (HP:0004311) | 1.63375572 |
| 146 | Hypercholesterolemia (HP:0003124) | 1.63111648 |
| 147 | Left ventricular hypertrophy (HP:0001712) | 1.61950870 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TAOK3 | 4.95319685 |
| 2 | PDK3 | 3.94290521 |
| 3 | PDK4 | 3.94290521 |
| 4 | OBSCN | 3.87364975 |
| 5 | TTN | 3.66912985 |
| 6 | AKT3 | 3.17083675 |
| 7 | TRIB3 | 2.71087751 |
| 8 | MST1R | 2.43000868 |
| 9 | PDK2 | 2.31585143 |
| 10 | PKN2 | 2.30809364 |
| 11 | DDR2 | 2.30467319 |
| 12 | RIPK1 | 2.23468163 |
| 13 | DMPK | 1.91175393 |
| 14 | MAPKAPK3 | 1.82710311 |
| 15 | PIK3CA | 1.76605926 |
| 16 | CDC42BPA | 1.67005241 |
| 17 | RIPK4 | 1.59346136 |
| 18 | MAPK7 | 1.58718689 |
| 19 | INSRR | 1.57288743 |
| 20 | STK24 | 1.56918544 |
| 21 | LMTK2 | 1.52366229 |
| 22 | TBK1 | 1.51017633 |
| 23 | MYLK | 1.43635928 |
| 24 | MOS | 1.42631798 |
| 25 | KSR2 | 1.38192882 |
| 26 | MAP3K5 | 1.35811771 |
| 27 | MUSK | 1.34610954 |
| 28 | FLT3 | 1.33850752 |
| 29 | PHKG1 | 1.33095855 |
| 30 | PHKG2 | 1.33095855 |
| 31 | MAPK12 | 1.32838510 |
| 32 | PIK3CG | 1.32117926 |
| 33 | ERN1 | 1.31940656 |
| 34 | EPHA3 | 1.24655762 |
| 35 | TESK1 | 1.24441622 |
| 36 | MAP2K3 | 1.23248607 |
| 37 | MAP3K14 | 1.23094726 |
| 38 | ACVR1B | 1.16199178 |
| 39 | TGFBR2 | 1.13861414 |
| 40 | MAP3K1 | 1.09967779 |
| 41 | NEK9 | 1.07409551 |
| 42 | IRAK3 | 1.05292810 |
| 43 | TRPM7 | 1.04163050 |
| 44 | LATS2 | 1.00930585 |
| 45 | ILK | 1.00134546 |
| 46 | STK38 | 0.98847029 |
| 47 | MAP3K3 | 0.98055974 |
| 48 | WNK4 | 0.97016596 |
| 49 | ZAK | 0.96364791 |
| 50 | MAP3K2 | 0.94614807 |
| 51 | EPHB1 | 0.93084305 |
| 52 | PRKD3 | 0.92246780 |
| 53 | PTK2 | 0.91921880 |
| 54 | PIM2 | 0.91856653 |
| 55 | BCKDK | 0.90695292 |
| 56 | JAK1 | 0.89268083 |
| 57 | ROCK1 | 0.88796707 |
| 58 | PRKAA2 | 0.88701257 |
| 59 | HIPK2 | 0.88554432 |
| 60 | LATS1 | 0.86760453 |
| 61 | ERBB3 | 0.86614810 |
| 62 | PTK6 | 0.86093540 |
| 63 | TYK2 | 0.83864759 |
| 64 | PTK2B | 0.81709422 |
| 65 | MAP3K13 | 0.80898105 |
| 66 | MARK2 | 0.79621422 |
| 67 | PRKD2 | 0.78653346 |
| 68 | IRAK4 | 0.77195213 |
| 69 | KSR1 | 0.76949995 |
| 70 | PAK3 | 0.76705838 |
| 71 | EPHB2 | 0.74822364 |
| 72 | PAK2 | 0.74308368 |
| 73 | TAOK2 | 0.72769451 |
| 74 | BMPR2 | 0.72683183 |
| 75 | FRK | 0.71815826 |
| 76 | PINK1 | 0.70017597 |
| 77 | MAP3K7 | 0.69708872 |
| 78 | STK3 | 0.68137061 |
| 79 | MARK1 | 0.67304968 |
| 80 | PAK6 | 0.66458026 |
| 81 | SGK2 | 0.66245779 |
| 82 | ARAF | 0.64634471 |
| 83 | PDGFRA | 0.64256043 |
| 84 | PRPF4B | 0.63518849 |
| 85 | PRKD1 | 0.62520933 |
| 86 | JAK2 | 0.62408946 |
| 87 | STK4 | 0.62077425 |
| 88 | ABL2 | 0.59738960 |
| 89 | ADRBK1 | 0.59550966 |
| 90 | PRKAA1 | 0.59515696 |
| 91 | SGK3 | 0.59363767 |
| 92 | CAMK2D | 0.57275566 |
| 93 | DYRK1B | 0.56908392 |
| 94 | ERBB4 | 0.56511905 |
| 95 | MATK | 0.55610251 |
| 96 | MAP3K6 | 0.55562582 |
| 97 | RPS6KA2 | 0.55225224 |
| 98 | MAPK4 | 0.54996867 |
| 99 | TAOK1 | 0.54959106 |
| 100 | PDPK1 | 0.54754951 |
| 101 | IKBKB | 0.53201708 |
| 102 | MET | 0.52381784 |
| 103 | CHUK | 0.50188964 |
| 104 | NEK1 | 0.50064811 |
| 105 | PKN1 | 0.49860439 |
| 106 | PDK1 | 0.49324304 |
| 107 | PRKG2 | 0.49085057 |
| 108 | NTRK1 | 0.48937031 |
| 109 | RET | 0.48907428 |
| 110 | CSK | 0.48453377 |
| 111 | GRK7 | 0.48142243 |
| 112 | NUAK1 | 0.46997152 |
| 113 | ZAP70 | 0.45958288 |
| 114 | JAK3 | 0.44587003 |
| 115 | KIT | 0.44554983 |
| 116 | MAP2K2 | 0.44498147 |
| 117 | MAP2K4 | 0.44425285 |
| 118 | FER | 0.44023747 |
| 119 | ICK | 0.43578088 |
| 120 | MAPK13 | 0.43474982 |
| 121 | STK10 | 0.43043157 |
| 122 | LRRK2 | 0.42745751 |
| 123 | PRKG1 | 0.42236280 |
| 124 | TEC | 0.41619890 |
| 125 | WNK1 | 0.41084257 |
| 126 | NME2 | 0.40977983 |
| 127 | MAP2K1 | 0.40599964 |
| 128 | BRAF | 0.40485408 |
| 129 | IRAK1 | 0.39889255 |
| 130 | IKBKE | 0.39692631 |
| 131 | CAMK2G | 0.39574697 |
| 132 | BMX | 0.38063186 |
| 133 | DAPK3 | 0.37396444 |
| 134 | STK38L | 0.36925024 |
| 135 | PIM1 | 0.36887487 |
| 136 | PBK | 0.35982255 |
| 137 | RAF1 | 0.35035317 |
| 138 | PDGFRB | 0.34713979 |
| 139 | TIE1 | 0.34559702 |
| 140 | MAP3K11 | 0.33718067 |
| 141 | NEK2 | 0.33629349 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.53385639 |
| 2 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.71495937 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.47043515 |
| 4 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.46529382 |
| 5 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.39813728 |
| 6 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.32070133 |
| 7 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.23788278 |
| 8 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.22400437 |
| 9 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.95735321 |
| 10 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.88993056 |
| 11 | Carbon metabolism_Homo sapiens_hsa01200 | 1.82083686 |
| 12 | Circadian rhythm_Homo sapiens_hsa04710 | 1.77745011 |
| 13 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.77443018 |
| 14 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.74786975 |
| 15 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.74447650 |
| 16 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.54465643 |
| 17 | Legionellosis_Homo sapiens_hsa05134 | 1.51843307 |
| 18 | Insulin resistance_Homo sapiens_hsa04931 | 1.49524500 |
| 19 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.48919910 |
| 20 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.46563734 |
| 21 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.41824196 |
| 22 | Leishmaniasis_Homo sapiens_hsa05140 | 1.40317984 |
| 23 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.40175105 |
| 24 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.39690987 |
| 25 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.30671111 |
| 26 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.29480083 |
| 27 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.24687428 |
| 28 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.23822667 |
| 29 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.23760757 |
| 30 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.20270491 |
| 31 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.19406058 |
| 32 | Viral myocarditis_Homo sapiens_hsa05416 | 1.14623668 |
| 33 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.14443621 |
| 34 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.14036692 |
| 35 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.12200588 |
| 36 | Galactose metabolism_Homo sapiens_hsa00052 | 1.12183232 |
| 37 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.11742620 |
| 38 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.09751538 |
| 39 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.09112467 |
| 40 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.07385241 |
| 41 | Renin secretion_Homo sapiens_hsa04924 | 1.04770234 |
| 42 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.03763984 |
| 43 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.03398124 |
| 44 | Mineral absorption_Homo sapiens_hsa04978 | 1.01784417 |
| 45 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.99015447 |
| 46 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.98548031 |
| 47 | Amoebiasis_Homo sapiens_hsa05146 | 0.98203865 |
| 48 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.97061422 |
| 49 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.96514859 |
| 50 | Tuberculosis_Homo sapiens_hsa05152 | 0.96496960 |
| 51 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.94021377 |
| 52 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.92641610 |
| 53 | Salmonella infection_Homo sapiens_hsa05132 | 0.91954368 |
| 54 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.91909560 |
| 55 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.86024980 |
| 56 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.85598708 |
| 57 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.85573598 |
| 58 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.84997801 |
| 59 | Malaria_Homo sapiens_hsa05144 | 0.83968553 |
| 60 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.83757763 |
| 61 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.82707039 |
| 62 | ABC transporters_Homo sapiens_hsa02010 | 0.82667158 |
| 63 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.81298018 |
| 64 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.80719854 |
| 65 | Parkinsons disease_Homo sapiens_hsa05012 | 0.80627158 |
| 66 | Alzheimers disease_Homo sapiens_hsa05010 | 0.79989802 |
| 67 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.79873282 |
| 68 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.78409012 |
| 69 | Pertussis_Homo sapiens_hsa05133 | 0.77499472 |
| 70 | Influenza A_Homo sapiens_hsa05164 | 0.76130269 |
| 71 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.75702419 |
| 72 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.75611821 |
| 73 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.75302964 |
| 74 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.75082810 |
| 75 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.74185318 |
| 76 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.74040645 |
| 77 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.74014964 |
| 78 | Huntingtons disease_Homo sapiens_hsa05016 | 0.73939192 |
| 79 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.73295180 |
| 80 | Prion diseases_Homo sapiens_hsa05020 | 0.72503558 |
| 81 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.71224908 |
| 82 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.70658206 |
| 83 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.69710285 |
| 84 | Bladder cancer_Homo sapiens_hsa05219 | 0.69685762 |
| 85 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.68086089 |
| 86 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.66928966 |
| 87 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.66220716 |
| 88 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.66139255 |
| 89 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.65803096 |
| 90 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.65566918 |
| 91 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.65559515 |
| 92 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.64869631 |
| 93 | Bile secretion_Homo sapiens_hsa04976 | 0.64868378 |
| 94 | Gap junction_Homo sapiens_hsa04540 | 0.64762868 |
| 95 | Lysine degradation_Homo sapiens_hsa00310 | 0.63332931 |
| 96 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.62058396 |
| 97 | Lysosome_Homo sapiens_hsa04142 | 0.61440976 |
| 98 | Peroxisome_Homo sapiens_hsa04146 | 0.60869926 |
| 99 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.60625088 |
| 100 | Shigellosis_Homo sapiens_hsa05131 | 0.59962115 |
| 101 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.59891572 |
| 102 | Other glycan degradation_Homo sapiens_hsa00511 | 0.59725521 |
| 103 | Phagosome_Homo sapiens_hsa04145 | 0.59498300 |
| 104 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.58845616 |
| 105 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.58085962 |
| 106 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.57783287 |
| 107 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.57129350 |
| 108 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.56992322 |
| 109 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.55333940 |
| 110 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.54922094 |
| 111 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.54868561 |
| 112 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.54822690 |
| 113 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.54756976 |
| 114 | Adherens junction_Homo sapiens_hsa04520 | 0.54369134 |
| 115 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.54081400 |
| 116 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.53970434 |
| 117 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.53844408 |
| 118 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.53742948 |
| 119 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.53370013 |
| 120 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.53118818 |
| 121 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.52879763 |
| 122 | Focal adhesion_Homo sapiens_hsa04510 | 0.52629923 |
| 123 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.52612872 |
| 124 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.52585362 |
| 125 | Glioma_Homo sapiens_hsa05214 | 0.52079153 |
| 126 | Endocytosis_Homo sapiens_hsa04144 | 0.51985496 |
| 127 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.51247674 |
| 128 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.51170855 |
| 129 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.50495117 |
| 130 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.50380780 |
| 131 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.50243709 |
| 132 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.49730122 |
| 133 | Tight junction_Homo sapiens_hsa04530 | 0.49609087 |
| 134 | Apoptosis_Homo sapiens_hsa04210 | 0.48764234 |
| 135 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.48617109 |
| 136 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.47752457 |
| 137 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.45580186 |
| 138 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.43536039 |
| 139 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.42671848 |
| 140 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.42474055 |
| 141 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.42327226 |
| 142 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.41586191 |
| 143 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.40280776 |
| 144 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.40121146 |
| 145 | Platelet activation_Homo sapiens_hsa04611 | 0.38665718 |
| 146 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.37906965 |
| 147 | Hepatitis C_Homo sapiens_hsa05160 | 0.37612874 |
| 148 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.37492961 |
| 149 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.35927504 |

